These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28838156)

  • 21. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 23. Introduction of Inactivated Poliovirus Vaccine in National Immunization Program and Polio Endgame Strategy.
    ; Vashishtha VM; Choudhary J; Yadav S; Unni JC; Jog P; Kamath SS; Sachdeva A; Srirampur S; Prajapati B; Parekh BJ
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S65-S69. PubMed ID: 27133231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
    Duintjer Tebbens RJ; Thompson KM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
    Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivated polio vaccine introduction in south Asia--1 year on.
    Hasman A; Garg G; Noble DJ
    Lancet Glob Health; 2016 Mar; 4(3):e150-1. PubMed ID: 26874544
    [No Abstract]   [Full Text] [Related]  

  • 28. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Bangladesh.
    Estivariz CF; Snider CJ; Anand A; Hampton LM; Bari TI; Billah MM; Chai SJ; Wassilak SG; Heffelfinger JD; Zaman K
    J Infect Dis; 2017 Jul; 216(suppl_1):S122-S129. PubMed ID: 28838154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction to inactivated polio vaccine and switch from trivalent to bivalent oral poliovirus vaccine worldwide, 2013-2016.
    Wkly Epidemiol Rec; 2015 Jul; 90(27):337-43. PubMed ID: 26151981
    [No Abstract]   [Full Text] [Related]  

  • 32. Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program.
    Shahzad A; Köhler G
    Vaccine; 2009 Aug; 27(39):5293-4. PubMed ID: 19638271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional-Dose Inactivated Poliovirus Vaccine Campaign - Sindh Province, Pakistan, 2016.
    Pervaiz A; Mbaeyi C; Baig MA; Burman A; Ahmed JA; Akter S; Jatoi FA; Mahamud A; Asghar RJ; Azam N; Shah MN; Laghari MA; Soomro K; Wadood MZ; Ehrhardt D; Safdar RM; Farag N
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1295-1299. PubMed ID: 29190264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe landing for global polio eradication: a perspective.
    Arita I; Francis DP
    Vaccine; 2011 Nov; 29(48):8827-34. PubMed ID: 21959326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.
    Thompson KM; Duintjer Tebbens RJ
    Expert Rev Vaccines; 2014 Feb; 13(2):221-34. PubMed ID: 24308581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.
    Bahl S; Verma H; Bhatnagar P; Haldar P; Satapathy A; Kumar KN; Horton J; Estivariz CF; Anand A; Sutter R
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(33):859-63. PubMed ID: 27559683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inactivated poliovirus vaccines: an inevitable choice for eliminating poliomyelitis].
    Vidor JD; Jean-Denis S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1021-1031. PubMed ID: 28057103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inactivated poliovirus vaccine].
    Shimizu H
    Nihon Rinsho; 2011 Sep; 69(9):1604-8. PubMed ID: 21922761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.